Misplaced Pages

This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages) This biography of a living person needs additional citations for verification. Please help by adding reliable sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libelous. Find sources: "Thomas Zeltner" – news · newspapers · books · scholar · JSTOR (July 2020) (Learn how and when to remove this message) The neutrality of this article is disputed. Relevant discussion may be found on the talk page. Please do not remove this message until conditions to do so are met. (July 2020) (Learn how and when to remove this message) (Learn how and when to remove this message)

Thomas Zeltner (born 16 November 1947) is a Swiss physician and lawyer. He is the current chairman and interim CEO of the WHO Foundation. He was also the former Secretary of Health of Switzerland Federal Department of Home Affairs FDHA. He has a long history in public health and has repeatedly been ranked among the 12 most influential political figures of Switzerland.

Zeltner is professor at the University of Bern, Switzerland, in Public Health and visiting scientist at the Harvard School of Public Health. He chairs the Swiss Research Institute for Public Health and Addiction (Zürich) and is President of UNESCO Commission of Switzerland. He advises the Swiss government in the implementation and future development of The National Health Policy. He is also the Vice Chair of the University Council of the Medical University of Vienna.

Past

Zeltner was born on 15 November 1947 in Bern, Switzerland. He graduated with an M.D. and an LL.M. (master's in law) from the University of Berne. He specialized in human pathology and forensic medicine before becoming the head of Medical Services at the Bern University Hospital. He held various faculty positions at the University of Bern and at the Harvard School of Public Health. He is Doctor of law (honoris causa) of the University of Neuchâtel, Switzerland.

In 1991, the Swiss Government appointed Zeltner as the 8th Director-General of the Swiss National Health Authority and Secretary of Health of Switzerland, a position he held until the end of 2009.

Under Zeltner's leadership, Switzerland developed in 1991 a pioneering illicit drug policy, which has received global attention. It is based on a 4-pillar strategy (prevention, harm reduction, therapy, and law enforcement), which is enshrined in the Swiss law on narcotic drugs. The harm reduction policy of Switzerland – which includes large-scale syringe exchange programs (also in prisons) and the medical prescription of heroin for chronic heroin addicts – was introduced against the strong opposition of the UN drug control authorities, but endorsed by a majority of the Swiss population in several popular referendums.

In 1999–2000, at the request of the then-Director General of WHO, Gro Harlem Brundtland, Zeltner chaired a committee which investigated the efforts of multinational tobacco companies to undermine tobacco control activities of the World Health Organization (2000). This landmark report marks the beginning of the development of the WHO Framework Convention on Tobacco Control (2003). With his efforts to reduce tobacco consumption in Switzerland, Zeltner became a favorite adversary of big tobacco and was nicknamed “the Tobacco Taliban."

As director of the Swiss Federal Office of Public Health, he presided over changes to transform the regulated market model of the Swiss health care sector into a more value- and consumer-driven health care system. The Swiss model guarantees access to affordable insurance to all, even if they have pre-existing medical problems. All residents are required to buy insurance even if they are currently healthy, so that the risk pool remains reasonably favorable. Finally subsidies are given to low income families to pay for their premiums. Even though the Swiss pay 12.18% of the GDP for health (data 2018), a majority of 78% considers that the system works well or very well. The Swiss health care model is gaining increased international interest, particularly in the U.S.

Zeltner was a member and vice-president of the executive board of the World Health Organization (WHO) (1999-2002). He chaired the committee to reform the governance rules of the WHO in 2002–4. He was also Executive President of the WHO Regional Committee for Europe (1994–95) and Chairman of the Governing Council of the International Agency for Research on Cancer, (1998-2000). Between 2012 and 2014, Zeltner served the World Health Organization (WHO) in the capacity of a Special Envoy. In this function he advised the Director General of WHO, Margaret Chan, in critical areas of the ongoing reform of this UN agency. The work was successfully completed by adoption of the Framework of Engagement with Non-State Actors (FENSA) by the World Health Assembly in May 2016.

Current position

In 2020, the World Health Organization (WHO) announced that Zeltner was one of the founding board members and the first chairman of the WHO Foundation. As of May 2020, Zeltner is acting as interim CEO of the WHO Foundation, an independent grant-making foundation focused on addressing the most pressing global health challenges of today and tomorrow.

He is co-founder of the Global Patient Safety Forum, a convening organization of world patient safety organizations; and a member of the steering board of the Global Patient Safety Challenge, Medication Safety, of the World Health Organization. He is a member of the editorial board of the journal Health Systems and Reform.

Since 1992, he has been Professor of Public Health at the University of Bern and is a visiting scientist at the Harvard School of Public Health (Boston). From 2018 to 2022 he serves as a member of the Board of the Medical University of Vienna (Austria). Zeltner has served as chairman of the board of the health insurer KPT until 2020, the leading online insurance company in Switzerland, which is repeatedly qualified as the best health insurer of Switzerland. He is also president of Blood Transfusion CRS Switzerland, the organization in charge of securing Switzerland's provision with blood and blood products.

References

1. "Une fondation suisse au secours (Financier) de l'OMS". Le Temps. 28 May 2020.
2. http://www.bilanz.ch/luxus/geballte-macht Die Mächtigsten: Geballte Macht
3. "Nicole Pepper for the Harm Reduction Coalition. Syringe Exchange in Prisons: The International Experience". Harm Reduction Coalition. 2007. Retrieved 31 Jul 2013.
4. "Report of the International Narcotics Control Board for 1995" (PDF). International Narcotics Control Board. 1996. Retrieved 31 Jul 2013.
5. Savary JF, Hallam C, Bewley-Taylor D (2009). "The Swiss Four Pillars Policy: an evolution from local experimentation to federal law" (PDF). The Beckley Foundation Drug Policy Programme. Briefing Paper Eighteen.
6. Zeltner T, Kessler DA, Martiny A, Randera F (Jul 2000). "Tobacco Company Strategies to Undermine Tobacco Control Activities at the World Health Organization. Report of the Committee of Experts on Tobacco Industry Documents" (PDF). Geneva, Switzerland. Archived from the original (PDF) on July 2, 2004. Retrieved 2 August 2013.
7. Reynolds LA, Tansey EM, eds. (2010) The transcript of a Witness Seminar organized by the Wellcome Trust Centre for the History of Medicine at UCL, in collaboration with the Department of Knowledge Management and Sharing, WHO, held in Geneva, on 26 February 2010. WHO Framework Convention on Tobacco Control. Retrieved 31 Jul 2013.
8. Ullekh NP (Jun 2, 2013). "Tobacco industry's bet on India & China may lead to surge in lifestyle diseases: Thomas Zeltner". The Economic Times (India).
9. "Swiss Federal Statistical Office: Costs, financing". Swiss Federal Administration. 2013. Retrieved 1 August 2013.
10. "Trend zu mehr Eigenverantwortung und weniger Solidarität". Interpharma. 2013. Retrieved 1 August 2013.
11. Cheng T-M (2010). "Understanding the 'Swiss watch' function of Switzerland's health system". Health Aff (Millwood). 29 (8): 1442–51. doi:10.1377/hlthaff.2010.0698. PMID 20707011.
12. Cassels A. (Apr 2013). "Change @ WHO: New approach to financing". World Health Organization. Retrieved 1 August 2013.
13. "WHO needs change". Nature Publishing Group. 12 May 2011. Retrieved 30 July 2013.
14. "WHO reform process: Landmark events of the WHO reform process from the initial consultation on the future of financing for WHO". World Health Organization. Archived from the original on September 8, 2012. Retrieved 30 July 2013.
15. "WHO Foundation Established to Support Critical Global Health Needs". World Health Organization (see also: "WHO dot int", and "whofoundationproject dot org" ). May 27, 2020. Archived from the original on May 27, 2020. Retrieved May 27, 2020. Founding Board Members are: Mr. Bob Carter, Ms. Clare Akamanzi and Professor Thomas Zeltner.
16. "Une fondation suisse au secours (Financier) de l'OMS". Le Temps. 28 May 2020.
17. "WHO launches fundraising foundation in Geneva". 28 May 2020.
18. "Die KPT ist erneut Spitze im Service" (in German). Konsumenteninfo AG. 19 September 2012. Retrieved 1 August 2013.

External links

• Thomas Zeltner on the History of Modern Biomedicine Research Group website

• 1947 births
• Living people
• People from Bern
• 20th-century Swiss politicians
• 21st-century Swiss politicians
• 20th-century Swiss physicians
• 21st-century Swiss physicians